0IIM.L
Esperion Therapeutics, Inc. [0IIM.L] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
0IIM.L Stock Summary
Top 10 Correlated ETFs
0IIM.L
Top 10 Correlated Stocks
0IIM.L
In the News
0IIM.L Financial details
Company Rating
-
Market Cap
387.95M
Income
-209.25M
Revenue
116.33M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
240
Optionable
No
Shortable
Yes
Earnings
07 May 2024
P/E
-1.49
Forward P/E
-
PEG
0.37
P/S
3.06
P/B
-0.76
P/C
-
P/FCF
-2.24
Quick Ratio
1.14
Current Ratio
1.58
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-2.12
EPS next Y
-
EPS next Q
-
EPS this Y
-42.33%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-10.78%
Revenue last 5Y
-4.75%
Revenue Q/Q
-5.06%
EPS Q/Q
35.14%
-
-
-
-
SMA20
-41.88%
SMA50
-50%
SMA100
-64.37%
Inst Own
-
Inst Trans
-
ROA
-94%
ROE
58%
ROC
-1.86%
Gross Margin
-33%
Oper. Margin
-151%
Profit Margin
-203%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.71-3.315
52W High
-
52W Low
-
RSI
35.42
Rel Volume
0.45
Avg Volume
26.66K
Volume
11.95K
Perf Week
-5.54%
Perf Month
-37.65%
Perf Quarter
-54.6%
Perf Half Y
-56.9%
-
-
-
-
Beta
0.822
-
-
Volatility
0.05%, 0.3%
Prev Close
3.19%
Price
0.9352
Change
2.7%
Company Profile
- Volume Average 26.66K
- Market Capitalization 387.95M
- Employee 240
- CEO Mr. Sheldon L. Koenig
- Headquarters Ann Arbor,MI,US
- IPO Date 2018-01-29
-
Website
https://www.esperion.com 
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascular disease or heterozygous familial hypercholesterolemia. The company has a license and collaboration agreement with Daiichi Sankyo Europe GmbH; and Serometrix to in-license its oral, small molecule PCSK9 inhibitor program. Esperion Therapeutics, Inc. was incorporated in 2008 and is headquartered in Ann Arbor, Michigan.
